Skip to main content

Table 2 Parameters calculated by CGM during glimepiride or repaglinide treatment

From: Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers

 

glimepiride

repaglinide

p

Max-BG(mmol/L)

13.5 ± 2.9

12.7 ± 3.6

0.51

Min-BG(mmol/L)

5.6 ± 0.9

5.3 ± 1.3

0.58

Max-Min (mmol/L)

7.9 ± 2.8

7.4 ± 3.4

0.63

SD (mmol/L)

1.9 ± 0.8

1.8 ± 1.0

0.78

Mean BG(mmol/L)

8.7 ± 1.6

8.0 ± 1.5

0.33

MAGE(mmol/L)

6.0 ± 3.1

3.6 ± 1.7

<0.05

Hours of under 3.9 mmol/L (% 24 hours)

0

0

-

Hours of over 10.0 mmol/L (% 24 hours)

31.3 ± 27.1

10.1 ± 10.5

<0.05

  1. Data are expressed as means ± SD. BG, blood glucose; Max-Min, difference between Max-BG and Min-BG; SD, standard deviation; MAGE, mean amplitude of glycemic excursions.